+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet | RobinsPost News & Noticias

Thermo Fisher: A Hold For Stability, Not For Outperformance


Thermo Fisher Scientific is a high-quality, defensive investment with a strong moat but faces revenue growth headwinds and limited upside. Learn more about TMO stock here. Read More

Beyond The Numbers: 11 Analysts Discuss Thermo Fisher Scientific Stock


Insights from analysts' 12-month price targets are revealed, presenting an average target of $521.82, a high estimate of $590.00, and a low estimate of $450.00. Surpassing the previous average price ... Read More

Here’s What Dragged Thermo Fisher Scientific (TMO) in Q2


Renaissance Investment Management, an investment management company, released its Q2 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market ... Read More

Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2


Loomis Sayles, an investment management company, released its “Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned ... Read More

TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth


Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. Read More

13 Analysts Assess Thermo Fisher Scientific: What You Need To Know


During the last three months, 13 analysts shared their evaluations of Thermo Fisher Scientific (NYSE:TMO), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the ... Read More

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued


Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening ... Read More

A Preview Of Thermo Fisher Scientific's Earnings


Thermo Fisher Scientific TMO is set to give its latest quarterly earnings report on Wednesday, 2025-07-23. Here's what investors need to know before the announcement. Analysts estimate that Thermo ... Read More

Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025


WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus